Hauser, S. L., Bar-Or, A., Cohen, J. A., Comi, G., Correale, J., Coyle, P. K., et al. (2020). Ofatumumab versus Teriflunomide in Multiple Sclerosis. The New England Journal Of Medicine, 383(6), 546-557. https://doi.org/10.1056/NEJMoa1917246 (Original work published 2020)